WA
QGENF

Winfield Associates’s QIAGEN NV QGENF Stock Holding History

Winfield Associates’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-175
Closed -$5K – 824
2016
Q4 		$5K Buy
175
+145
+483% +$4.14K ﹤0.01% 450
2016
Q3 		$1K Hold
30
– – ﹤0.01% 683
2016
Q2 		$1K Sell
30
-170
-85% -$5.67K ﹤0.01% 695
2016
Q1 		$4K Buy
+200
New +$4K ﹤0.01% 425

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Winfield Associates's QGENF Position: Q1 2017 in Review

Winfield Associates sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 175 shares — an estimated $5K sold.

Winfield Associates first reported a position in QGENF in Q1 2016 and held it in 4 quarters. The position peaked at $5K in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Winfield Associates reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Winfield Associates sold 175 QIAGEN NV shares in Q1 2017, an estimated $5K.
  • Winfield Associates first reported a position in QIAGEN NV in Q1 2016 and held it in 4 quarters.
  • Winfield Associates's QIAGEN NV position peaked at $5K in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Winfield Associates's 13F filing for Q1 2017, filed 10 May 2017.